Towa Pharmaceutical Co., Ltd.
TWAPF · OTC
3/31/2025 | 3/31/2024 | 3/31/2023 | 3/31/2022 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $45,471,000 | $29,650,000 | $24,257,000 | $32,830,000 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $61,449,000 | $71,657,000 | $54,392,000 | $50,748,000 |
| Inventory | $108,287,000 | $101,072,000 | $92,927,000 | $72,701,000 |
| Other Curr. Assets | $32,099,000 | $15,339,000 | $11,414,000 | $10,585,000 |
| Total Curr. Assets | $247,306,000 | $217,718,000 | $182,990,000 | $166,864,000 |
| Property Plant & Equip (Net) | $168,423,000 | $153,642,000 | $127,004,000 | $100,857,000 |
| Goodwill | $28,115,000 | $32,568,000 | $34,613,000 | $44,647,000 |
| Intangibles | $17,726,000 | $18,018,000 | $18,331,000 | $9,454,000 |
| Long-Term Investments | $3,213,000 | $3,006,000 | $1,283,000 | $1,098,000 |
| Tax Assets | $6,037,000 | $0 | $5,303,000 | $5,075,000 |
| Other NC Assets | $0 | $5,696,000 | $1,820,000 | $1,935,000 |
| Total NC Assets | $223,514,000 | $212,930,000 | $188,354,000 | $163,066,000 |
| Other Assets | $3,000 | $5,000 | $3,000 | $5,000 |
| Total Assets | $470,823,000 | $430,653,000 | $371,347,000 | $329,935,000 |
| Liabilities | – | – | – | – |
| Payables | $26,990,000 | $26,990,000 | $31,284,000 | $17,041,000 |
| Short-Term Debt | $24,105,000 | $13,232,000 | $22,751,000 | $64,934,000 |
| Tax Payable | $4,852,000 | $7,926,000 | $1,190,000 | $4,285,000 |
| Deferred Revenue | $0 | $7,926,000 | $14,129,000 | $15,644,000 |
| Other Curr. Liab. | $31,992,000 | $44,996,000 | $9,175,000 | $13,169,000 |
| Total Curr. Liab. | $87,939,000 | $80,118,000 | $78,529,000 | $115,073,000 |
| LT Debt | $206,878,000 | $189,124,000 | $150,314,000 | $79,194,000 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $4,382,000 | $5,519,000 | $5,611,000 | $3,500,000 |
| Total NC Liab. | $211,260,000 | $194,643,000 | $155,925,000 | $82,694,000 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $13,184,000 | $0 | $0 | $0 |
| Total Liabilities | $299,199,000 | $274,761,000 | $234,454,000 | $197,767,000 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $4,717,000 | $4,717,000 | $4,717,000 | $4,717,000 |
| Retained Earnings | $150,502,000 | $134,452,000 | $121,232,000 | $122,131,000 |
| AOCI | $14,150,000 | $14,491,000 | $8,714,000 | $3,090,000 |
| Other Equity | $2,255,000 | $2,232,000 | $2,229,000 | $2,229,000 |
| Total Equity | $171,624,000 | $155,892,000 | $136,893,000 | $132,168,000 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $470,823,000 | $430,653,000 | $371,347,000 | $329,935,000 |
| Net Debt | $185,512,000 | $172,706,000 | $148,808,000 | $111,298,000 |